(secondQuint)The OBSTACLE Hypoglycemia Study (MK-0000-158).

 Patients will be evaluated for participation in the study during their usual visit to participating diabetes care clinics.

 Addition of sulfonylurea will be an unbiased decision of the participating physicians based on the clinical needs of the participating patients.

.

 The OBSTACLE Hypoglycemia Study (MK-0000-158)@highlight

This study will assess the correlation between glycemic control and the hypoglycemia symptom score in patients with Type 2 diabetes, 12 weeks after addition of a sulfonylurea to an ongoing regime of oral hypoglycemic agents.

